Cigna Group

More Details of Cigna Group Company

Company Info

Company codeCI

Company nameCigna Group

IPO dateApr 01, 1982

Founded at2018

CEOMr. Eric P. Palmer

Number of employees73500

Security typeOrdinary Share

Fiscal year-endApr 01

Address- -

City- -

Stock exchangeNYSE Consolidated

Country- -

Postal code- -

Phone- -

Website- -

Company codeCI

IPO dateApr 01, 1982

Founded at2018

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. David M. Cordani, CPA

Chairman of the Board, President, Chief Executive Officer

653.62K

-3.90%

Mr. Brian C. Evanko

Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare

60.38K

+20.44%

Ms. Noelle K. Eder

Executive Vice President, Global Chief Information Officer

29.75K

+28.79%

Ms. Donna F. Zarcone, CPA

Independent Director

26.09K

+2.11%

Mr. Eric C. Wiseman

Lead Independent Director

22.52K

+2.45%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President and Chief Health Officer

9.04K

-3.11%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

5.47K

+10.93%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

5.47K

--

Ms. Kathleen M. Mazzarella

Independent Director

5.47K

+10.93%

Ms. Kimberly A. Ross

Independent Director

3.87K

+16.16%

Name

Name/Position

Position

Shareholding

Change

Mr. David M. Cordani, CPA

Chairman of the Board, President, Chief Executive Officer

653.62K

-3.90%

Mr. Brian C. Evanko

Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare

60.38K

+20.44%

Ms. Noelle K. Eder

Executive Vice President, Global Chief Information Officer

29.75K

+28.79%

Ms. Donna F. Zarcone, CPA

Independent Director

26.09K

+2.11%

Mr. Eric C. Wiseman

Lead Independent Director

22.52K

+2.45%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President and Chief Health Officer

9.04K

-3.11%

Revenue Breakdown

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

By BusinessUSD

Name

Revenue

Proportion

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.47B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.05B

0.00%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.47B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.05B

0.00%

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.49%

BlackRock Institutional Trust Company, N.A.

4.89%

State Street Global Advisors (US)

4.64%

MFS Investment Management

4.10%

T. Rowe Price Associates, Inc.

3.86%

Other

73.00%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.49%

BlackRock Institutional Trust Company, N.A.

4.89%

State Street Global Advisors (US)

4.64%

MFS Investment Management

4.10%

T. Rowe Price Associates, Inc.

3.86%

Other

73.00%

Type

Shareholder

Proportion

Investment Advisor

41.63%

Investment Advisor/Hedge Fund

39.78%

Pension Fund

2.42%

Research Firm

2.24%

Hedge Fund

1.99%

Bank and Trust

1.66%

Sovereign Wealth Fund

1.26%

Corporation

1.25%

Holding Company

0.43%

Other

7.30%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2874

255.12M

93.18%

-3.90M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.88M

2024Q1

2865

261.01M

89.38%

-14.29M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.62M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

2023Q1

2710

268.82M

90.70%

-14.56M

2022Q4

2688

273.81M

91.52%

-15.32M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

25.97M

9.49%

+22.81K

+0.08%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.38M

4.89%

+8.79K

+0.06%

Dec 31, 2024

State Street Global Advisors (US)

12.71M

4.64%

-105.72K

-0.82%

Dec 31, 2024

MFS Investment Management

11.22M

4.1%

+489.58K

+4.55%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.56M

3.86%

-1.11M

-9.58%

Dec 31, 2024

Fidelity Management & Research Company LLC

9.98M

3.64%

-1.67M

-14.37%

Dec 31, 2024

Dodge & Cox

8.77M

3.2%

-16.80K

-0.19%

Dec 31, 2024

Sanders Capital, LLC

8.05M

2.94%

+154.41K

+1.95%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.95M

2.17%

+101.73K

+1.73%

Dec 31, 2024

GQG Partners, LLC

4.02M

1.46%

+737.09K

+22.44%

Dec 31, 2024

Related ETFs

Update time: 12 hours ago

Name

Proportion

Future Fund Active ETF

12.58%

iShares U.S. Healthcare Providers ETF

9.88%

Monarch Dividend Plus Index ETF

5.07%

Cambria LargeCap Shareholder Yield ETF

4.21%

VictoryShares Free Cash Flow ETF

4.05%

First Trust Large Cap US Equity Select ETF

3.21%

Davis Select US Equity ETF

3.15%

Fidelity Blue Chip Value ETF

2.41%

Hennessy Stance ESG ETF

2.39%

Brandes US Value ETF

2.36%

Future Fund Active ETF

Proportion12.58%

iShares U.S. Healthcare Providers ETF

Proportion9.88%

Monarch Dividend Plus Index ETF

Proportion5.07%

Cambria LargeCap Shareholder Yield ETF

Proportion4.21%

VictoryShares Free Cash Flow ETF

Proportion4.05%

First Trust Large Cap US Equity Select ETF

Proportion3.21%

Davis Select US Equity ETF

Proportion3.15%

Fidelity Blue Chip Value ETF

Proportion2.41%

Hennessy Stance ESG ETF

Proportion2.39%

Brandes US Value ETF

Proportion2.36%

Dividend

A total of 5.74B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

309.830USD

Cigna Group

309.830

Overview

Company